103 related articles for article (PubMed ID: 2121567)
1. Effect of insulin on oxidation of intracellularly and extracellularly derived glucose in patients with NIDDM. Evidence for primary defect in glucose transport and/or phosphorylation but not oxidation.
Butler PC; Kryshak EJ; Marsh M; Rizza RA
Diabetes; 1990 Nov; 39(11):1373-80. PubMed ID: 2121567
[TBL] [Abstract][Full Text] [Related]
2. Multiple defects of both hepatic and peripheral intracellular glucose processing contribute to the hyperglycaemia of NIDDM.
Vaag A; Alford F; Henriksen FL; Christopher M; Beck-Nielsen H
Diabetologia; 1995 Mar; 38(3):326-36. PubMed ID: 7758880
[TBL] [Abstract][Full Text] [Related]
3. Metabolic pathways of glucose in skeletal muscle of lean NIDDM patients.
Kelley DE; Mokan M; Mandarino LJ
Diabetes Care; 1993 Aug; 16(8):1158-66. PubMed ID: 8375246
[TBL] [Abstract][Full Text] [Related]
4. 31P nuclear magnetic resonance measurements of muscle glucose-6-phosphate. Evidence for reduced insulin-dependent muscle glucose transport or phosphorylation activity in non-insulin-dependent diabetes mellitus.
Rothman DL; Shulman RG; Shulman GI
J Clin Invest; 1992 Apr; 89(4):1069-75. PubMed ID: 1556176
[TBL] [Abstract][Full Text] [Related]
5. Different sensitivity of glucose and amino acid metabolism to insulin in NIDDM.
Luzi L; Petrides AS; De Fronzo RA
Diabetes; 1993 Dec; 42(12):1868-77. PubMed ID: 8243833
[TBL] [Abstract][Full Text] [Related]
6. Characterization of cellular defects of insulin action in type 2 (non-insulin-dependent) diabetes mellitus.
Del Prato S; Bonadonna RC; Bonora E; Gulli G; Solini A; Shank M; DeFronzo RA
J Clin Invest; 1993 Feb; 91(2):484-94. PubMed ID: 8432857
[TBL] [Abstract][Full Text] [Related]
7. Intracellular glucose oxidation and glycogen synthase activity are reduced in non-insulin-dependent (type II) diabetes independent of impaired glucose uptake.
Thorburn AW; Gumbiner B; Bulacan F; Wallace P; Henry RR
J Clin Invest; 1990 Feb; 85(2):522-9. PubMed ID: 2105341
[TBL] [Abstract][Full Text] [Related]
8. Intracellular defects in glucose metabolism in obese patients with NIDDM.
Kelley DE; Mokan M; Mandarino LJ
Diabetes; 1992 Jun; 41(6):698-706. PubMed ID: 1587397
[TBL] [Abstract][Full Text] [Related]
9. Dose-response characteristics of impaired glucose oxidation in non-insulin-dependent diabetes mellitus.
Henry RR; Thorburn AW; Beerdsen P; Gumbiner B
Am J Physiol; 1991 Jul; 261(1 Pt 1):E132-40. PubMed ID: 1858869
[TBL] [Abstract][Full Text] [Related]
10. Metabolic effects of hyperglycemia and hyperinsulinemia on fate of intracellular glucose in NIDDM.
Henry RR; Gumbiner B; Flynn T; Thorburn AW
Diabetes; 1990 Feb; 39(2):149-56. PubMed ID: 2227122
[TBL] [Abstract][Full Text] [Related]
11. Effects of basal insulin supplementation on disposition of mixed meal in obese patients with NIDDM.
McMahon M; Marsh HM; Rizza RA
Diabetes; 1989 Mar; 38(3):291-303. PubMed ID: 2492963
[TBL] [Abstract][Full Text] [Related]
12. Roles of glucose transport and glucose phosphorylation in muscle insulin resistance of NIDDM.
Bonadonna RC; Del Prato S; Bonora E; Saccomani MP; Gulli G; Natali A; Frascerra S; Pecori N; Ferrannini E; Bier D; Cobelli C; DeFronzo RA
Diabetes; 1996 Jul; 45(7):915-25. PubMed ID: 8666143
[TBL] [Abstract][Full Text] [Related]
13. Decreased muscle glucose transport/phosphorylation is an early defect in the pathogenesis of non-insulin-dependent diabetes mellitus.
Rothman DL; Magnusson I; Cline G; Gerard D; Kahn CR; Shulman RG; Shulman GI
Proc Natl Acad Sci U S A; 1995 Feb; 92(4):983-7. PubMed ID: 7862678
[TBL] [Abstract][Full Text] [Related]
14. Comparison of extracellular and net glucose oxidation measured isotopically and by indirect calorimetry during high and low glucose turnover.
McMahon MM; Marsh HM; Rizza RA
Am J Clin Nutr; 1991 May; 53(5):1138-42. PubMed ID: 1902346
[TBL] [Abstract][Full Text] [Related]
15. Role of lipid oxidation in pathogenesis of insulin resistance of obesity and type II diabetes.
Felber JP; Ferrannini E; Golay A; Meyer HU; Theibaud D; Curchod B; Maeder E; Jequier E; DeFronzo RA
Diabetes; 1987 Nov; 36(11):1341-50. PubMed ID: 3311856
[TBL] [Abstract][Full Text] [Related]
16. Effect of the antilipolytic nicotinic acid analogue acipimox on whole-body and skeletal muscle glucose metabolism in patients with non-insulin-dependent diabetes mellitus.
Vaag A; Skött P; Damsbo P; Gall MA; Richter EA; Beck-Nielsen H
J Clin Invest; 1991 Oct; 88(4):1282-90. PubMed ID: 1918378
[TBL] [Abstract][Full Text] [Related]
17. The effect of non-insulin-dependent diabetes mellitus and obesity on glucose transport and phosphorylation in skeletal muscle.
Kelley DE; Mintun MA; Watkins SC; Simoneau JA; Jadali F; Fredrickson A; Beattie J; Thériault R
J Clin Invest; 1996 Jun; 97(12):2705-13. PubMed ID: 8675680
[TBL] [Abstract][Full Text] [Related]
18. Fasting hyperglycemia normalizes oxidative and nonoxidative pathways of insulin-stimulated glucose metabolism in noninsulin-dependent diabetes mellitus.
Mandarino LJ; Consoli A; Kelley DE; Reilly JJ; Nurjhan N
J Clin Endocrinol Metab; 1990 Dec; 71(6):1544-51. PubMed ID: 2121778
[TBL] [Abstract][Full Text] [Related]
19. In vivo glucose metabolism in obese and type II diabetic subjects with or without hypertension.
Bonora E; Bonadonna RC; Del Prato S; Gulli G; Solini A; Matsuda M; DeFronzo RA
Diabetes; 1993 May; 42(5):764-72. PubMed ID: 8482434
[TBL] [Abstract][Full Text] [Related]
20. Assessment of insulin action in NIDDM in the presence of dynamic changes in insulin and glucose concentration.
Katz H; Homan M; Jensen M; Caumo A; Cobelli C; Rizza R
Diabetes; 1994 Feb; 43(2):289-96. PubMed ID: 8288053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
